Given a set of PSA values, we answer the question: "Is its information content typical for the existence of a prostate cancer, or not ?" Our findings support PSA screening.
The task is two-fold. First: Given a set of measured PSA(t) values. Find the constants DT1 and DT2 without any (previous) knowledge of the values of a and b, and give a quantitative estimate (standard deviation, std) of the reliability of the results. This is a purely mathematical application, independent of any medical considerations, see 1, 2 . Second: Show that formula (1) represents real patient data, calibrate DT2 versus diagnostic findings, and apply the method to early diagnosis of prostate cancer.
Figure 1 (top) shows the agreement of 10 measured PSA data points with the curve calculated from the formula (1). It establishes the action of a second, faster growth mechanism, and demonstrates, that the method is capable to predict this mechanism already 20 months earlier, on the basis of the first 7 data points, as represented in the bottom of Fig. 1 .
Out of a random collection 3 of measured PSA data, 36 sets have been chosen, and analyzed with formula (1). The reader is invited to consult the corresponding graphs which show the reductions of the various PSA time-evolutions to their exponential components. They are available from www.psadynamics.com (→ "Wissenschaftliche Grundlagen", in english)
The resulting frequencies of the components' doubling times are displayed in Fig. 2 For the data of a single person, it is natural (and true) that 0 < DT2 < DT1 for DT1 > 0. However, for a collection of doubling times from different persons, this is no more applicable. It is thus a non-trivial finding, that there is a region of short doubling times, as displayed in the bottom part of Fig. 2 , where the red and green events (the DT2 and DT1 values) are entirely separated. This is the first and main message of this paper. (Points ± 9 % std assumed, resulting χ 2 /d = 2.6). In the (semi-log) plot, the exponential components are represented by the straight, dashed lines. Evidence for the existence of a second growth processs comes from the value found for DT2 = 10 ± 4 months, which is incompatible with the value found for DT1 = 430 months. Bottom: This conclusion could have been reached 20 months earlier ! The analysis, based on the first 7 PSA values, would have predicted DT2 = 6 ± 5 months (in perfect statistical agreement), and would have led to the same conclusion. The patient is 49 years old. Note that all of the PSA values, in this part of the figure, are below (the widely used reference value of) 4 ng/ml. (Figure: χ 2 /d = 0.95).
We note in passing, that only an adequate mathematical procedure is able to produce this clean separation.
In order to arm this formal result with diagnostic power, we have calibrated DT against a new and independent PSA data set 3 with a total of 411 patients, having a diagnosis of a Benign Prostatic Hyperplasia (BPH), and no prostate cancer. None of the doubling times was shorter than 27 months. The second main result of this paper thus is, that the "DT1-free" region of Fig. 2 is also "BPH free".
To conclude, we answer the question, posed in the abstract, with reference to the set of PSA values in Fig. 1 : Its information content, expressed by the value of DT2 = 10 ± 4 months, which falls well into the "DT1-free region", is typical for a cell-reproduction process other than BPH, even though the PSA values are low.
Early PSA screening helps by providing early data points as needed by the algorithm to disentangle the processes. Top: Measured PSA doubling times DT1 due to the first cell population are distributed over a wide range (34 cases of 36 reach from -500 to +500 months), whereas those from the unveiled second population (DT2) cluster around small values. Bottom: Zoom of the top subpicture. Clustering of the DT2 values. In the range from 0 to 13 months, 30 (of 36) values of DT2 are located, in contrast to none (of 36) of DT1. With high probability, they are not BPH events.
